155 related articles for article (PubMed ID: 29473345)
21. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
23. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
24. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer.
Wei H; Li Y; Du Y; Ma J
Future Oncol; 2018 Nov; 14(27):2811-2820. PubMed ID: 30051729
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
Yoon HJ; Kim BS; Moon CM; Yoo J; Lee KE; Kim Y
PLoS One; 2018; 13(4):e0196110. PubMed ID: 29698422
[TBL] [Abstract][Full Text] [Related]
26. Nomograms combined with
Li XC; Wang S; Zhu JR; Wang YP; Zhou YN
Transl Cancer Res; 2020 Jul; 9(7):4393-4412. PubMed ID: 35117805
[TBL] [Abstract][Full Text] [Related]
27. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
28. Loss expression of PHLPP1 correlates with lymph node metastasis and exhibits a poor prognosis in patients with gastric cancer.
Wang Z; Shu H; Wang Z; Li G; Cui J; Wu H; Cai S; He W; He Y; Zhan W
J Surg Oncol; 2013 Dec; 108(7):427-32. PubMed ID: 24037758
[TBL] [Abstract][Full Text] [Related]
29. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
30. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
31. Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.
Kim Y; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Gastric Cancer; 2019 Jan; 22(1):37-47. PubMed ID: 29926315
[TBL] [Abstract][Full Text] [Related]
32. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma.
Yang H; Tian W; Zhou B
Genomics; 2022 Jan; 114(1):361-377. PubMed ID: 34933074
[TBL] [Abstract][Full Text] [Related]
33. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
34. Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.
Jiang Z; Yu T; Fan Z; Yang H; Lin X
Cell Physiol Biochem; 2017; 43(3):1090-1099. PubMed ID: 28977783
[TBL] [Abstract][Full Text] [Related]
35. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
Zhong M; Jiang Q; Jin R
IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
[TBL] [Abstract][Full Text] [Related]
36. GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer.
Wang JX; Zhou JF; Huang FK; Zhang L; He QL; Qian HY; Lai HL
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3857-3865. PubMed ID: 28975979
[TBL] [Abstract][Full Text] [Related]
37. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
38. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
39. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.
Wang Y; He L; Cheng Y
Clin Transl Oncol; 2018 Feb; 20(2):212-220. PubMed ID: 28681313
[TBL] [Abstract][Full Text] [Related]
40. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
